Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,771,404
-$64,072 QoQ
Shares Held
523,895
-30.7% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 149 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Derivatives in ACRS
reported options exposure · as of Sep 30, 2023CallValue
$393,190
CallShares
57,400
PutValue
$685,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. ACRS ranks #202 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in ACRS
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,771,404 | 523,895 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,835,476 | 756,127 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,170,270 | 1,053,246 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,953,470 | 1,554,458 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,449,079 | 3,837,380 | Shares | Sole | 2025-08-14 | |
| 2025-04-28 | $7,538,667 | 5,543,138 | Shares | Sole | 2025-05-05 | |
| 2025-03-31 | $6,325,246 | 4,134,148 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,858,436 | 1,959,047 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,456,437 | 3,005,598 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,670,535 | 3,336,850 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,059,130 | 3,273,492 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,653,329 | 3,479,361 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $393,190 | 57,400 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $13,480,663 | 1,967,980 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $685,000 | 100,000 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $8,576,861 | 827,084 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $518,500 | 50,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $492,381 | 60,863 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $404,500 | 50,000 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $3,274,393 | 207,898 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,209,464 | 203,905 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,775,164 | 198,794 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $969,112 | 56,213 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,125,451 | 352,507 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $727,000 | 50,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $5,781,438 | 321,191 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $900,000 | 50,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $3,518,391 | 200,364 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,649,824 | 343,247 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,351,751 | 208,926 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $724,220 | 281,798 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $623,594 | 384,935 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||